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    We found that caffeine significantly inhibited epidermal growth factor (EGF)- 
and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cell transformation in 
the JB6 mouse epidermal cell line.  The tumor promoter-induced cell 
transformation was also blocked by treatment with an adenosine A1 receptor 
antagonist, 8-phenyltheophylline.  Caffeine slightly attenuated activation of 
EGF-induced activator protein 1 (AP-1) activation, which play important roles in 
cell transformation, but only at the highest concentration examined (1 mM).  
Interestingly, pretreatment with caffeine suppressed EGF-induced 
phosphorylation and activation of Akt and ribosomal p70 S6 protein kinase, a 
target of Akt, without inhibiting phosphatidylinositol 3-kinase activation.  The 
inhibition of Akt activation of caffeine was not a result of its adenosine receptor 
antagonism.  Because Akt plays a key role in signal transduction pathways leading 
to cell proliferation and apoptosis, our results provide novel insight into possible 
mechanisms of the chemotherapeutic effect of caffeine.  
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INTRODUCTION 
    Methylxanthines, such as caffeine, have a number of biological effects, including 
stimulation of muscle contraction [1], alterations in glucose metabolism [2,3], 
immunomodulatory effects [4], induction of apoptosis [5], and anti-cancer or 
anti-carcinogenic effects [6-8].  These pleiotropic effects may be explained by 
inhibition of phosphodiesterase (PDE) and an antagonistic effect on adenosine receptors.  
On the other hand, caffeine potentiates the sensitivity of tumor cells to ionizing 
radiation or anti-tumor agents [8,9].  In our university hospital, radiochemotherapy or 
chemotherapy combined with caffeine is used to treat high-grade soft tissue sarcomas in 
the Department of Orthopedic Surgery [10,11].  Although the chemotherapeutic effect 
of caffeine is concentration-dependent, the plasma concentration in patients is limited to 
80 μg/ml (412 μM) to avoid toxicity.  The effect of caffeine may result from disruption 
of the G2/M DNA damage checkpoint by the inhibition of ataxia-telangiectasia-mutated 
protein kinase (ATM) and/or ATM/Rad3-related protein kinase (ATR) and their 
downstream signaling effectors [12,13].  ATM and ATR are members of the 
phosphatidylinositol 3-kinase (PI3K)-related kinase (PIKK) family [14].  The PIKK 
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family members share a C-terminal kinase domain bearing significant sequence 
homology to the catalytic domains of mammalian and yeast PI3K.  Methylxanthines 
are known to inhibit phosphoinositide metabolism [15,16] and the PI3K signaling 
pathway [2,17].  Thus, caffeine’s effects may involve other mechanisms than PDE 
inhibition and adenosine receptor antagonism at cancer chemotherapeutic 
concentrations.  We were therefore interested in the role of altered signal transduction 
pathways in the biological mechanisms of caffeine. 
    The JB6 cell system of clonal genetic variants, which are promotion-sensitive (P+) 
or promotion-resistant (P-), is an excellent model for studying signal transduction at the 
molecular level in various stages of carcinogenesis [18-23].  The JB6 P+, P- and 
transformed variants are a series of cell lines representing ‘earlier-to-later’ stages of 
preneoplastic-to-neoplastic progression [19,21].  JB6 P+ cells transform when 
stimulated with epidermal growth factor (EGF) or 
12-O-tetradecanoylphorbol-13-acetate (TPA), forming colonies in soft agar [19,21].  
The transformation is thought to involve activation of activator protein 1 (AP-1) 
[18,22-25], which regulates the transcription of various genes related to cellular 
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inflammation, proliferation and apoptosis [26].  It plays a key role not only in 
neoplastic transformation in tumor promotion [24,25], but also in tumor progression and 
metastasis [27].  In addition, we have demonstrated that phosphatidylinositol 3-kinase 
(PI3K) and its downstream effector, Akt, are closely involved in epidermal growth 
factor (EGF)-induced cell transformation in JB6 P+ cells [28].  PI3K is central to the 
coordinated control of multiple cell-signaling pathways leading to tumor development, 
including cell proliferation, apoptosis and migration [29,30], and Akt plays a pivotal 
role in the PI3K-signaling pathway [31].  In this study, we found that caffeine inhibited 
EGF-induced cell transformation.  To test the hypothesis that caffeine might modulate 
the AP-1 and/or the PI3K/Akt signaling pathways, we investigated the effect of caffeine 
on the signaling pathways induced by EGF in JB6 P+ cells. 
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MATERIALS AND METHODS 
Materials 
    Eagle's minimal essential medium (MEM), L-glutamine and basal medium Eagle 
(BME) were from Life Technologies (Rockville, MD); fetal bovine serum (FBS), 
gentamicin, ribonuclease A and caffeine were from Sigma (St. Louis, MO, USA); the 
PI3K inhibitor, LY29402, was from Calbiochem (La Jolla, CA, USA); the Akt 
immunoprecipitation kinase and S6 kinase assay kits were from Upstate Biotechnology 
Inc. (Lake Placid, NY, USA); the Akt antibody and phospho-specific Akt (serine 473), 
ribosomal p70 S6 protein kinase (p70 S6K) antibody and phospho-specific p70 S6K 
(threonine 389), and PhosphoPlus p44/42 mitogen activated protein (MAP) kinase 
antibody kits were from Cell Signaling Technology Inc. (Beverly, MA, USA); the 
anti-Akt1/2 antibody and agarose conjugated with monoclonal anti-phosphotyrosine 
antibody (PY99) were from Santa Cruz (Santa Cruz, CA, USA); propidium iodide and 
8-phenyltheophylline (8-PTH) were from Wako Pure Chemical Industries, Ltd. (Osaka, 
Japan).  The cyclic adenosine monophosphate (cAMP) EIA system was purchased from 




    The stable transfectant cells expressing dominant negative mutant Akt1 
(DNM-Akt1) were obtained as reported previously [28].  The mouse epidermal JB6 Cl 
41 cell line and its stable transfectants, P+1-1 (AP-1 reporter transfectant) and 
DNM-Akt1, were grown at 37°C in MEM supplemented with 5% heat-inactivated FBS, 
2 mM L-glutamine, and 25 μg/ml gentamicin. 
 
Anchorage-independent Growth Assay 
    JB6 Cl 41 cells and its transfectant cells, DNM-Akt1, in aliquots of 1x104 cells, 
were exposed to EGF (10 ng/ml) or TPA (10 ng/ml) with or without the indicated 
concentrations of caffeine or 8-PTH in 1 ml of 0.33% BME agar containing 10% FBS 
over 3.5 ml of 0.5% BME agar medium containing 10% FBS.  The cultures were 
maintained in a 37°C, 5% CO2 incubator and the cell colonies were scored at 14 days 
after exposure of the cells to EGF or TPA. 
 
 10
Cell Proliferation Assay 
    JB6 Cl 41 cells were suspended in 5% FBS/MEM at a density of 1x104 cells/ml.  
The cell suspension (1 ml) was placed in each well of a 24-well plate and incubated for 
24 h.  Then, the indicated concentrations of caffeine were added and incubation was 
continued for 48 h at 37°C.  After incubation for the indicated periods, the cell number 
was counted under a microscope. 
 
Flow Cytometry 
    The cell cycle of JB6 Cl 41 cells treated with EGF (10 ng/ml) and/or caffeine (1 
mM) for 24 h or 48 h was examined by flow cytometry using a FACS Calibur (Becton 
Dickinson Co. Ltd., San Jose, USA) as described previously [32].  
 
Assay of AP-1 Activity 
    JB6 AP-1 reporter stable P+1-1 cells (7x103) were seeded in a 96-well plate.  After 
24 h incubation, the cells were starved by replacing the medium with 0.1% FBS/MEM 
for 24 h.  Then, the cells were pretreated with the indicated concentrations of caffeine 
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for 1 h and cultured with 10 ng/ml EGF in the presence or absence of caffeine for 24 h.  
The cells were extracted with lysis buffer, and luciferase activity was measured with a 
BioOrbit 1253 luminometer (BioOrbit , Turku, Finland).  Relative AP-1 activity was 
calculated as described previously [33]. 
 
Assay for cAMP Production 
    JB6 Cl 41 cells (7x103) were seeded in a 96-well plate.  After a 24 h incubation, the 
cells were starved by replacing the medium with 0.1% FBS/MEM for 24 h.  Then, the 
cells were treated or not treated with caffeine (1 mM) in the absence or presence of EGF 
(10 ng/ml) or forskolin (100 nM) for the indicated periods.  The medium was aspirated, 
and the cells were lysed using a lysis buffer (Amersham Biosciences Corp.).  
Intercellular cAMP content was determined by a cAMP EIA system (Amersham 
Biosciences Corp.) according to the manufacturer’s instructions. 
 
Immunoblotting 
    Immunoblotting was carried out as described previously [33].  In brief, JB6 Cl 41 
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cells were cultured to 80% confluence.  The cells were starved in 0.1 % FBS/MEM for 
24 h at 37°C.  Then the medium was changed to fresh 0.1% FBS/MEM and the cells 
were incubated for another 2-4 h at 37°C.  Before exposure of the cells to EGF, they 
were treated or not treated with caffeine for 1 h.  Then, EGF (10 ng/ml) was added and 
cells were subsequently incubated for an additional 30 min at 37°C.  The cells were 
then lysed, and immunoblot analysis was performed by using antibodies against Akt, 
p70 S6K and Erks or phospho-specific antibodies against the phosphorylated proteins.  
Antibody-bound proteins were detected by luminescence assay  (ECL Western Blotting 
Kit, Amersham Biosciences Corp.) and analyzed using a BAS-1000 lumino-imaging 
analyzer (Fuji Film, Tokyo, Japan). 
 
p70 S6K and Akt Kinase Immunoprecipitation Assay 
    JB6 Cl 41 cells were treated or not treated with caffeine or 8-PTH before treatment 
with EGF (10 ng/ml) or TPA (10 ng/ml) for the indicated time. Lysates were prepared 
from the cells and immunoprecipitation was carried out using 20 μl of anti-Akt1/2 
(Santa Cruz) or 3 μg of anti-p70 S6K antibodies (Cell Signaling).  The enzyme 
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immune complex was washed three times with 0.5 ml of lysis buffer, and once with 100 
μl of assay dilution buffer (20 mM MOPS, pH 7.2, 25 mM β-glycerophosphate, pH 7.0, 
1 mM sodium orthovanadate, 1 mM DTT).  For the Akt kinase assay, the enzyme 
immune complex was added to 10 μl of assay dilution buffer, 40 μM protein kinase A 
inhibitor peptide, 0.4 mM Akt substrate peptide, and 1 μCi of [γ-32P]ATP.  For the p70 
S6K assay, the enzyme immune complex was added to 20 μl of assay dilution buffer, 10 
μl of inhibitor cocktail, 50 μM S6 kinase substrate peptide, and 1 μCi of [γ-32P] ATP.  
The respective reaction mixtures were incubated for 10 min at 30°C, then centrifuged, 
and 30 μl of the supernatant fraction was transferred onto P81 phosphocellulose paper.  
The P81 paper was washed three times in 0.75% phosphoric acid and then once in 
acetone, and the γ-32P incorporation was measured by scintillation counting. 
 
PI3K Assay 
    JB6 Cl 41 cells pretreated with caffeine for 1 h were exposed to EGF (10 ng/ml) for 
5 min.  The cells were lysed in 400 μl of lysis buffer (20 mM Tris-HCl, pH 7.4, 137 
mM NaCl, 1 mM MgCl2, 10% glycerol, 1% Nonidet P-40, 1 mM DTT, 1 mM sodium 
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orthovanadate, 1 mM PMSF, 10 μM aprotinin, 10 μM leupeptin).  The lysate was 
sonicated and centrifuged, and the supernatant fraction was incubated with 20 μl of 
agarose conjugated with a monoclonal anti-phosphotyrosine antibody (PY99), with 
gentle rocking overnight at 4°C.  Then, PI3K activity was determined as described 
previously [34].  The radiolabeled spots of phosphatidylinositol 3-monophosphate 
(PI3P) that indicates PI3K activation were quantified using the BAS-2000 bio-imaging 
analyzer (Fuji Film). 
 
Statistical Analysis 
The significance of differences in this study was determined by using Student’s t test. 
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RESULTS 
Inhibition of tumor promoter-induced cell transformation by caffeine 
    In the JB6 Cl 41 promotion-sensitive (P+) cell line, in which transformed colonies 
are induced by EGF or TPA, caffeine significantly blocked EGF- and TPA-induced cell 
transformation in a concentration-dependent manner (Figure 1A).  The inhibition of 
cell transformation by caffeine was not due to growth inhibition, because the 
concentration range of caffeine that blocked cell transformation had no effect on cell 
proliferation (Figure 1B).   
    We also analyzed the cell cycle in cells treated with EGF and/or caffeine for 24 hr 
or 48 hr.  EGF tended to increase the proportion of cells in S-phase, but caffeine had no 
effect on the cell cycle distribution (data not shown). 
 
Involvement of intracellular cAMP and adenosine receptor antagonism in 
EGF-induced cell transformation 
    As shown in Figure 2A, the cAMP content was not enhanced in cells treated with 
caffeine (1 mM) and/or EGF (10 ng/ml) for the indicated time.  In contrast, when the 
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cells were treated with caffeine in the presence of forskolin (100 nM), a cAMP elevator, 
caffeine significantly enhanced the increase of cAMP content induced by forskolin.   
    We also assessed the effect of 8-phenyltheophylline (8-PTH), a selective A1 
adenosine receptor antagonist [35], on EGF- and TPA-induced cell transformation.  
Treatment with 8-PTH significantly inhibited tumor promoter-induced cell 
transformation (Fig. 2B).  
 
Effect of caffeine on EGF-induced AP-1 activation 
    Caffeine slightly attenuated EGF-induced AP-1 activation, but only at the highest 
concentration examined (1 mM) (Figure 3A).  Extracellular signal-regulated kinases 
(Erks) have been shown to be necessary components in the pathway leading to AP-1 
activation and neoplastic transformation, and caffeine also tended to inhibit 
EGF-induced Erks phosphorylation at 1 mM (Figure 3B). 
 
Caffeine inhibited Akt activation induced by EGF 
    Expression of dominant negative mutant Akt1 (DNM-Akt1) in JB6 Cl 41 cells 
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inhibited cell transformation induced by EGF, but not TPA (Figure 4A).  Akt was 
activated by treatment with EGF, whereas TPA had no effect (Figure 4B).    
    We then investigated whether caffeine modulates EGF-induced Akt activation.  
Treatment with caffeine inhibited EGF-induced phosphorylation at serine 473 and 
activation of Akt in the same concentration range as that causing inhibition of 
EGF-induced cell transformation (Figure 5).  Furthermore, caffeine suppressed 
EGF-induced phosphorylation at threonine 389 and activation of ribosomal p70 S6 
protein kinase (p70 S6K), a target of Akt (Figure 6).   
    On the other hand, caffeine had no effect on EGF-induced PI3K activation (Figure 
7).  To test whether caffeine directly inhibits the kinase activities of Akt and p70 S6K 
induced by EGF, we performed Akt and p70 S6K kinase reactions in the presence of 
caffeine.  The enzymes were immunoprecipitated from lysate of cells treated with EGF 
(10 ng/ml) by using antibody to Akt or p70 S6K.  However, treatment with caffeine did 
not directly affect EGF-induced activation of either Akt or p70 S6K (data not shown). 
    Although several studies have shown that an adenosine A1 receptor-mediated signal 
transduction pathway is involved in Akt activation [36,37], 8-PTH did not block 
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EGF-induced Akt activation (Figure 8). 
 
DISCUSSION 
    In this study, we investigated the influence of chemotherapeutic concentrations of 
caffeine on signal transduction in the mouse epidermal JB6 P+ cell line, JB6 Cl 41, 
stimulated with EGF.  We found that caffeine inhibited EGF- and TPA-induced cell 
transformation in a concentration-dependent manner.  The inhibitory effects of caffeine 
may be mediated by inhibition of PDE, an antagonistic effect on adenosine receptors, or 
G2/M arrest through ATM/ATR inhibition.  Dong et al. [38] have reported that 
forskolin, a cAMP elevator, reversed the formation of transformed colonies of 
neoplastic epidermal JB6 RT101 cells.  Treatment of cells with caffeine (1 mM) in the 
absence or presence of EGF did not change the intracellular cAMP content.  An 
increased intracellular cAMP content in the presence of caffeine was observed only 
when the cells were treated with forskolin, suggesting that phosphodiesterase inhibitors 
are needed for cAMP elevators, such as forskolin, to stimulate increases in intracellular 
cAMP content.  On the other hand, caffeine had no effect on cell proliferation or on the 
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cell cycle in cells treated with EGF (data not shown).  Thus, the inhibition by caffeine 
of EGF-induced cell transformation is not mediated by cell growth inhibition or by 
induction of G2/M arrest through inhibition of ATM/ATR.  In contrast, we found that 
8-PTH, an adenosine A1 receptor antagonist, blocked EGF- and TPA-induced cell 
transformation.  In addition to 8-PTH, a non-selective adenosine receptor antagonist, 
CGS-15943, also suppressed EGF-induced cell transformation (data not shown).  
Adenosine receptors are coupled to a complicated network of signaling pathways via 
G-proteins [39].  Therefore, the inhibitory effect of caffeine on tumor promoter-induced 
cell transformation appears to result from the modulation of adenosine 
receptor-dependent signaling pathways.   
   Many reports, including ours, have suggested that AP-1 activity is a critical factor for 
tumor promoter-induced cell transformation in JB6 P+ cells [18,22-25,33].  Therefore, 
we also assessed whether caffeine inhibits EGF-induced AP-1 activation.  Caffeine 
slightly attenuated EGF-induced AP-1 activation and Erks phosphorylation, which are 
necessary components in the pathway leading to AP-1 transcriptional activation [40,41], 
but only at the highest concentration examined (1 mM), suggesting that AP-1 activation 
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may not be substantially involved in caffeine’s inhibition of cell transformation. 
      In a wide range of cellular systems, Akt controls intracellular pathways 
responsible for preventing cell death, and promoting cell cycle progression, 
anchorage-independent growth and cell migration [28,31,42,43].  Akt was originally 
characterized as a cellular counterpart of the viral oncogene, v-akt, from the 
transforming retrovirus AKT8 [44].  It is overexpressed in a large proportion of ovarian, 
pancreatic, prostate and breast cancers [45-47].  Expression of DNM-Akt1 in JB6 Cl 41 
cells significantly impaired EGF-induced cell transformation, in agreement with our 
previous report [28], whereas cell transformation induced by TPA, which did not 
activate Akt, was unaffected.  Thus, Akt activation plays an important role in cell 
transformation induced by EGF, but not TPA, in JB6 P+ cells.  Caffeine inhibited 
EGF-induced Akt activation and phosphorylation of Akt at serine 473 in the same 
concentration range as that causing inhibition of cell transformation, suggesting a 
relationship between these phenomena.  The inhibition of Akt activation by caffeine is 
not specific to JB6 Cl 41 cells, because we have observed a similar effect in a mouse 
preadipose cell line, MC3T3-G2/PA6, stimulated with insulin [2].  
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    The activation of p70 S6K is known to require signaling through mammalian target 
of rapamycin (mTOR) [48].  mTOR is reported to be essential for cell transformation 
induced by the oncogenes p3k and akt [49] and to be directly phosphorylated by Akt 
[50,51].  Caffeine inhibited EGF-induced p70 S6K activation and phosphorylation at 
threonine 389, a rapamycin-sensitive site.  Thus, the inhibition of EGF-induced p70 
S6K activation by caffeine may result from the impairment of mTOR through a 
blockade of Akt activation.  PI3K and p70 S6K are constitutively activated in small cell 
lung cancer cells and anchorage-independent growth in the cells is mediated through 
Akt and p70 S6K-dependent pathways [52].  p70 S6K is also amplified or 
overexpressed in human breast cancer [53,54].  Therefore, blocking the activation of 
p70 S6K may also, in part, be involved in the inhibitory effect of caffeine on 
EGF-induced cell transformation.   
    On the other hand, the mechanism by which caffeine blocked activation of Akt is 
not clear.  Foukas et al. [17] have shown by in vitro kinase assay that caffeine directly 
inhibited PI3K activation.  Therefore, we assessed the influence of caffeine on PI3K 
activation induced by EGF and found that caffeine did not affect EGF-induced PI3K 
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activation.  We previously showed that tea polyphenols directly inhibited ultraviolet 
B-induced p70 S6K activation in this cell line [34].  However, caffeine did not directly 
affect EGF-induced activation of either Akt or p70 S6K (data not shown).  Furthermore, 
Akt is reported to be be activated through the adenosine A1 receptor [36,37], but 8-PTH, 
which blocked cell transformation, had no effect on EGF-induced Akt activation.  Thus, 
inhibition of Akt activation by caffeine was not a result of its adenosine receptor 
antagonism.  The mechanism through which caffeine blocked activation of Akt requires 
further study. 
    Caffeine, in addition to its effect on cell cycle regulation, has been reported to 
induce apoptosis in cells treated with or without DNA-damaging agents [13,55,56].  
Akt inactivates the apoptotic function via phosphorylation of BAD, caspase-9, Forkhead 
family, IkappaB kinase, and cAMP-response element-binding protein [42].  
Furthermore, it phosphorylates the murine double minute 2 (MDM2) protein, promoting 
its nuclear localization, and increasing p53 degradation [57].  The phosphorylation of 
MDM2 by activated Akt is suggested to play an important role in impairing p53 
functions, including p53-dependent apoptosis.  Therefore, the inhibition of Akt by 
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caffeine might induce apoptosis. 
    In this study, we found that caffeine blocked tumor promoter-induced cell 
transformation in JB6 cells, possibly through its adenosine receptor A1 antagonistic 
effect.  We also found that caffeine significantly inhibited EGF-induced Akt activation.  
Akt plays a pivotal role in signal transduction pathways leading to preventing cell death, 
cell cycle progression, malignant transformation and cell migration [28,31,41,42].  
Therefore, our results provide novel insight into the possible mechanisms of the cancer 
chemotherapeutic action of caffeine.  
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    Figure 1.  Inhibition of tumor promoter-induced cell transformation by 
caffeine.  A, Aliquots of 104 JB6 Cl 41 cells were treated with EGF (10 ng/ml) or TPA 
(10 ng/ml) with or without the indicated concentration of caffeine in 0.33% BME agar 
containing 10% FBS over 0.5% BME agar medium containing 10% FBS.  Cell 
colonies were scored after incubation for 14 days at 37˚C in a 5% CO2 incubator.  Data 
are expressed as means ± S.E. of independent three experiments.  * Significantly 
different from EGF or TPA alone at P < 0.05.  B, JB6 Cl 41 cells were suspended in 5% 
FBS/MEM at a density of 1x104 cells/ml.  The cell suspension (1 ml) was placed in 
each well of a 24-well plate and incubated for 24 h.  Then, the indicated concentrations 
of caffeine were added and incubation was continued for 48 h at 37˚C in a 5% CO2 
incubator.  After the indicated periods, cells were counted under a microscope.  Data 
are expressed as means ± S.E. of four independent experiments. 
  
    Figure 2.  Involvement of intracellular cAMP and adenosine receptor 
antagonism in EGF-induced cell transformation.  A, JB6 Cl 41 cells (7x103) were 
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seeded in a 96-well plate.  After a 24 h incubation, the cells were starved by replacing 
the medium with 0.1% FBS/MEM, followed by incubation for 24 h.  Then, the cells 
were treated or not treated with caffeine (1 mM) in the absence or presence of EGF (10 
ng/ml) or forskolin (100 nM) for the indicated times.  The cells were lysed, and the 
intercellular cAMP content was determined using a cAMP EIA system.  Data are 
expressed as means ± S.E. of three independent experiments.  # Significantly different 
from the untreated control at P < 0.05.  * Significantly different from caffeine 
treatment only at P < 0.05.  § Significantly different from forskolin treatment only at P 
< 0.05.  B, Aliquots of 104 JB6 Cl 41 cells were treated with EGF (10 ng/ml) or TPA 
(10 ng/ml) with or without the indicated concentration of 8-PTH in 0.33% BME agar 
containing 10% FBS over 0.5% BME agar medium containing 10% FBS.  Cell 
colonies were scored after incubation for 14 days at 37˚C in a 5% CO2 incubator.  Data 
are expressed as means ± S.E. of three independent experiments.  * Significantly 
different from EGF or TPA alone at P < 0.05.   
 
    Figure 3.  Effect of caffeine on EGF-induced AP-1 activation and Erks 
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phosphorylation.  A, JB6 AP-1 reporter stable P+1-1 cells were seeded in a 96-well 
plate.  After a 24 h incubation, the cells were starved by replacing the medium with 
0.1% FBS/MEM, and incubation was continued for an additional 24 h.  Then, the cells 
were pretreated with the indicated concentration of caffeine for 1 h and cultured with 10 
ng/ml EGF for an additional 24 h.  The AP-1 activity was measured with a luciferase 
activity assay as described under ‘‘MATERIALS AND METHODS’’.  The results are 
shown as relative AP-1 activity, expressed as means ± S.E. of five independent 
experiments.  * Significantly different from EGF alone at P < 0.05.  B, JB6 Cl 41 cells 
(80% confluence) were starved by replacing the medium with 0.1% FBS/MEM and 
incubation was continued for 24 h.  The cells were pretreated with caffeine for 1 h at 
the indicated concentration, then treated or not treated with EGF (10 ng/ml) and further 
cultured for 30 min.  The cells were lysed and the phosphorylation levels were 
estimated by immunoblotting with a phospho-specific p44/42 MAP kinases (Erks) 
antibody.  The intensity of each phospho-specific band was normalized to the that of 
the band of the respective non-phosphorylated protein.  The results are shown relative 
phosphorylation expressed as means ± S.E. of five independent experiments. 
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    Figure 4.  Inhibition of EGF-induced cell transformation by introduction of 
DNM-Akt1.  A, Aliquots of 104 JB6 Cl 41 cells or DNM-Akt1 cells were treated with 
EGF (10 ng/ml) or TPA (10 ng/ml) in 0.33% BME agar containing 10% FBS over 0.5% 
BME agar medium containing 10% FBS.  Cell colonies were scored after incubation 
for 14 days at 37˚C in 5% CO2.  Data are the means ± S.E. of three independent 
experiments.  * Significantly different from EGF alone at P < 0.05.  B, JB6 Cl 41 cells 
(80% confluence) were starved by replacing the medium with 0.1% FBS/MEM, and 
incubation was continued for 24 h.  The cells were then treated or not treated with EGF 
(10 ng/ml) or TPA (10 ng/ml) and further cultured for the indicated time.  The cells 
were lysed and Akt was immunoprecipitated using an anti-Akt1/2 antibody.  Activities 
were assessed using a specific substrate peptide and [γ-32P]ATP.  Data are expressed as 
means ± S.E. of at least three independent experiments.   
 
    Figure 5.  Inhibition of EGF-induced phosphorylation and activation of Akt 
by caffeine.  JB6 Cl 41 cells (80% confluence) were starved by replacing the medium 
 39
with 0.1% FBS/MEM, and incubation was continued for 24 h.  The cells were 
pretreated with caffeine for 1 h at the indicated concentration, then treated or not treated 
with EGF (10 ng/ml) and further cultured for 30 min.  A, The cells were lysed and Akt 
was immunoprecipitated using an anti-Akt1/2 antibody.  The respective activities were 
assessed using a specific substrate peptide and [γ-32P]ATP.  Data are expressed as 
means ± S.E. of at least three independent experiments.  * Significantly different from 
EGF alone at P < 0.05.  B, The cells were lysed and the phosphorylation levels were 
estimated by immunoblotting with a phospho-specific antibody for Akt.  The intensity 
of each phospho-specific band was normalized to the band of the respective 
non-phosphorylated protein.  The results are shown as relative phosphorylation, 
expressed as means ± S.E. of four independent experiments.  * Significantly different 
from EGF alone at P < 0.05. 
  
    Figure 6.  Inhibition of EGF-induced phosphorylation and activation of p70 
S6K by caffeine.  JB6 Cl 41 cells (80% confluence) were starved by replacing the 
medium with 0.1% FBS/MEM, and incubation was continued for 24 h.  The cells were 
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pretreated with caffeine for 1 h at the indicated concentration, then treated or not treated 
with EGF (10 ng/ml) and futher cultured for 30 min.  A, The cells were lysed and p70 
S6K was immunoprecipitated using an anti-p70 S6K antibody.  The respective 
activities were assessed using a specific substrate peptide and [γ-32P]ATP.  Data are 
expressed as means ± S.E. of at least three independent experiments.  * Significantly 
different from EGF alone at P < 0.05.  B, The cells were lysed and the phosphorylation 
levels were estimated by immunoblotting with a phospho-specific antibody for p70 S6K.  
The intensity of each phospho-specific band was normalized to the band of the 
respective non-phosphorylated protein.  The results are shown as relative 
phosphorylation, expressed as means ± S.E. of four independent experiments.  * 
Significantly different from EGF alone at P < 0.05.  
 
    Figure 7.  Effect of caffeine on EGF-induced PI3K activation.  JB6 Cl 41 cells 
(80% confluence) were starved by replacing the medium with 0.1% FBS/MEM, and 
incubation was continued for 24 h.  The cells were pretreated with caffeine or 
LY294002 for 1 h at the indicated concentration, then treated or not treated with EGF 
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(10 ng/ml) and further cultured for 5 min.  The cells were lysed and the activities of 
PI3K were determined as described in "MATERIALS AND METHODS’’.  PI3P, 
phosphoinositol 3-monophosphate. 
 
    Figure 8.  Effect of 8-PTH on EGF-induced Akt activation.  JB6 Cl 41 cells 
(80% confluence) were starved by replacing the medium with 0.1% FBS/MEM, and 
incubation was continued for 24 h.  The cells were pretreated with 8-PTH for 1 h at the 
indicated concentrations, then treated or not treated with EGF (10 ng/ml) and further 
cultured for 30 min.  The cells were lysed and Akt was immunoprecipitated using an 
anti-Akt1/2 antibody.  The activities were assessed using a specific substrate peptide 
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